Mineralys Therapeutics, Inc.
Mineralys Therapeutics is a clinical biotechnology company developing a therapy for cardiorenal disease. We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that we are initially developing for the treatment of […]
January 18, 2023 Read More